スタッフ紹介 Surgeons


専任講師 阿部 雄太

専任講師
阿部 雄太(あべ ゆうた)

  • 1998年 慶應義塾大学医学部卒
  • 日本消化器外科学会指導医
    日本肝胆膵外科学会高度技能専門医
    日本内視鏡外科学会技術認定医(肝臓)
  • ■専門領域■
    腹腔鏡下解剖学的肝切除、肝胆膵血管合併切除、ナビゲーション手術、肝門部胆管癌手術
  • ■コメント■
    低浸襲治療の代表である腹腔鏡下肝切除に、最新の手術ナビゲーションを応用することで、従来の肝切除を超えた精緻な肝切除を実践しています。一方で直径2mmの肝動脈に対するマイクロ血管吻合や重要大血管の合併切除再建を駆使した難治性腫瘍の拡大手術、つまり諦めない治療にも積極的に取り組んでいます。豊富な経験とあらゆる最新技術を駆使して、すべての患者様に全力で向き合うことによる「後悔しない治療」を追求します。

経歴

1998年慶應義塾大学医学部外科 研修医
2002年京都大学移植外科 医員
2004年医療財団法人荻窪病院外科 医員
2006年米国Louisiana州立大学分子生物学教室・外科学教室 研究員
2009年東京医科大学八王子医療センター 消化器外科・移植外科 助教
2012年慶應義塾大学病院 一般・消化器外科 助教
2015年慶應義塾大学病院 一般・消化器外科 専任講師(学部内)
2018年慶應義塾大学病院 一般・消化器外科 専任講師

主たる研究内容

1.血管合併切除を伴う切除困難症例に対する多科横断的治療
2.肝門部領域癌に対する血管合併切除とあらたな手術戦略
3.腹腔鏡下肝切除術
4.肝臓・膵臓・胆道領域の手術ナビゲーション

資格

  • 日本外科学会専門医
  • 日本消化器外科学会指導医
  • 日本肝胆膵外科学会高度技能専門医, 評議員
  • 日本内視鏡外科学会技術認定医(腹腔鏡下肝切除術)
  • 日本がん治療認定医
  • 日本移植学会移植認定医

所属学会

  • 日本外科学会
  • 日本消化器外科学会
  • 日本肝胆膵外科学会
  • 日本がん治療認定医
  • 日本移植学会

受賞歴

2020年Best Doctors®:The Best Doctors in Japan™ 2020-2021
2019年第31回日本肝胆膵外科学会学術集会 Outstand Award
2018年the 26th International EAES Congress:the best video presentation
2014年日本内視鏡外科学会 カールストルツ賞(学会ベストビデオ賞2014)
2008年ルイジアナ州立大学リサーチグランドアワード 2008
2003年慶應義塾大学外科胆道班ベストレジデント2003

助成金

2014年度
~2016年度
新規の遺伝子網羅的解析法による肝細胞癌分子標的薬に対する薬剤耐性遺伝子の同定
:文科省科学研究費 基盤研究(C)
2010年度
~2011年度
小腸グラフト遊走性抗原特異的制御性T細胞導入による小腸移植後免疫寛容誘導法の確立
:文科省科学研究費 若手研究(B)

論 文

1.Tomita K, Shimazu M, Takano K, Gunji T, Ozawa Y, Sano T, Chiba N, Abe Y, Kawachi S. Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases. World J Surg Oncol 18(1): web掲載7頁, 2020
2.Nakano Y, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Takeuchi A, Takemura Y, Kitagawa Y. Predictive Factors for Liver Volume and Function Recovery After Resection Using Three-Dimensional Analysis. HPB (Oxford) 22(6): 845-854, 2020
3.Ishii M, Itano O, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Takeuchi A, Tsujikawa H, Abe T, Kitagawa Y. Pre-hepatectomy Type IV Collagen 7S Predicts Post-Hepatectomy Liver Failure and Recovery. World J Gastroenterol 26(7): 725-739, 2020
4.Yokose T, Kitago M, Matsusaka Y, Masugi Y, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Endo Y, Toyama K, Iwabuchi Y, Takemura R, Ishii R, Nakahara T, Okuda S, Jinzaki M, Kitagawa Y. Usefulness of 18 F-fluorodeoxyglucose Positron Emission tomography/computed Tomography for Predicting the Prognosis and Treatment Response of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. Cancer Med 9(12): 4059-4068, 2020
5.Yokose T, Kitago M, Matsuda S, Sasaki Y, Masugi Y, Nakamura Y, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Yusuke F, Nakano Y, Endo Y, Abe K, Tokino T, Kitagawa Y. Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Cancer Sci 111(6): 2174-2182, 2020
6.Chiba N, Abe Y, Nakagawa M, Koganezawa I, Yokozuka K, Kobayashi T, Hikita K, Ozawa Y, Sano T, Tomita K, Tsutsui R, Kawachi S. The "Tenting Sign of the Hepatic Vein" Is Important for Laparoscopic Anatomical Hepatectomy Along the Major Hepatic Vein. J Gastrointest Surg 24(6): 1448-1451, 2020
7.Kubota N, Ojima H, Hatano M, Yamazaki K, Masugi Y, Tsujikawa H, Fujii-Nishimura Y, Ueno A, Kurebayashi Y, Shinoda M, Kitago M, Abe Y, Kitagawa Y, Sakamoto M. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin. Pathol Int 70(4): 199-209, 2020
8.Fujita Y, Matsuda S, Sasaki Y, Masugi Y, Kitago M, Yagi H, Abe Y, Shinoda M, Tokino T, Sakamoto M, Kitagawa Y. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis. Cancer Sci 111(2): 739-748, 2020
9.Minagawa T, Yamazaki K, Masugi Y, Tsujikawa H, Ojima H, Hibi T, Abe Y, Yagi H, Kitago M, Shinoda M, Itano O, Kitagawa Y, Sakamoto M. Activation of extracellular signal-regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes. Hepatology Research 50(3): 353-364, 2020
10.Wakabayashi T, Abe Y, Itano O, Shinoda M, Kitago M, Yagi H, Hibi T, Oshima G, Minagawa T, Kitagawa Y. Laparoscopic Repeat Liver Resection after Open Liver Resection is Safe and Feasible: A Comparative Study from a Single Center. J Minim Access Surg 16(1): 59-65, 2020
11.Ibuki S, Abe Y, Shimata K, Narita Y, Irie T, Yamamoto H, Sugawara Y, Hibi T. Living Donor Liver Transplantation With a Left Trisection Plus Caudate Lobe Graft. Liver Transpl 25(8): 1276-1280, 2019
12.Takemura Y, Hibi T, Shinoda M, Obara H, Minagawa T, Kitago M, Yagi H, Abe Y, Matsubara K, Oshima G, Hori S, Hoshino K, Yamada Y, Itano O, Takano Y, Kuroda T, Hasegawa N, Kitagawa Y. Methicillin-resistant Staphylococcus aureus carriers are vulnerable to bloodstream infection after living donor liver transplantation. Clin Transplant 33(12): web掲載8頁, 2019
13.Endo Y, Oshima G, Hibi T, Shinoda M, Sakurai M, Koda Y, Izawa Y, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Fukushima A, Yokose T, Mori T, Kuroda T, Kitagawa Y. Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report. Transplantation 103(11): 375-377, 2019
14.Nakano Y, Kitago M, Shinoda M, Yagi H, Abe Y, Takano K, Oshima G, Takeuch A, Endo Y, Kitagawa Y. Prognostic significance of the postoperative level and recovery rate of serum albumin in patients with curatively resected pancreatic ductal adenocarcinoma. Mol Clin Oncol 11(3): 270-278, 2019
15.Shimoda H, Yagi H, Higashi H, Tajima K, Kuroda K, Abe Y, Kitago M, Shinoda M, Kitagawa Y. Decellularized liver scaffolds promote liver regeneration after partial hepatectomy. Sci Rep 91(1): web掲載11頁, 2019
16.Ariizumi S, Ban D, Abe Y, Kumamoto T, Koizumi S, Tanabe M, Shinoda M, Endo I, Otsubo T, Yamamoto M. High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular Carcinoma. Anticancer Res 39(8): 4219-4225, 2019
17.Endo Y, Kitago M, Aiura K, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Itano O, Fukada J, Masugi Y, Kitagawa Y. Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study. World J Surg Oncol 145(): web掲載8頁, 2019
18.Wakabayashi T, Felli E, Memeo R, Mascagni P, Abe Y, Kitagawa Y, Pessaux P. Short-term outcomes of laparoscopic repeat liver resection after open liver resection: a systematic review. Surg Endosc 33(7): 2083-2092, 2019
19.Takeuchi M, Kawakubo H, Abe Y, Kanazawa A, Ehara K, Kinugasa Y, Kinoshita T, Nomura A, Kitagawa Y. Assessment of the Safety of the New Hybrid Pencil Type Energy (NP) Device Used Close to the Recurrent Laryngeal Nerve in a Porcine Model: Comparison With a Conventional Electrosurgical Knife. Surg Innov 26(2): 219-226, 2019
20.Chiba N, Abe Y, Yokozuka K, Hikita K, Kobayashi T, Sano T, Tomita K, Tsutsui R, Kawachi S. Surgical Technique of Pancreatic Parenchyma Transection-Delayed Approach (PPTDA) in Hepatopancreatoduodenectomy for Hilar Cholangiocarcinoma. J Gastrointest Surg 23(3): 613-616, 2019
21.Wakabayashi T, Abe Y, Kanazawa A, Oshima G, Kodai S, Ehara K, Kinugasa Y, Kinoshita T, Nomura A, Kawakubo H, Kitagawa Y. Feasibility Study of a Newly Developed Hybrid Energy Device Used During Laparoscopic Liver Resection in a Porcine Model. Surg Innov 26(3): 350-358, 2019
22.Kawaida M, Yamazaki K, Tsujikawa H, Fukuma M, Abe Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M. Diffuse and canalicular patterns of glypican-3 expression reflect malignancy of hepatocellular carcinoma. Pathol Int 69(3): 125-134, 2019
23.Wakabayashi T, Yagi H, Tajima K, Kuroda K, Shinoda M, Kitago M, Abe Y, Oshima G, Hirukawa K, Itano O, Kitagawa Y. Efficacy of New Polylactic Acid Nonwoven Fabric as a Hemostatic Agent in a Rat Liver Resection Model. Surg Innov 26(3): 312-320, 2019
24.Koizumi W, Kitago M, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Inomata K, Kawakubo H, Kawaida M, Kitagawa Y. Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature. BMC Cancer 19(1): web掲載5頁, 2019
25.Wakabayashi T, Obara H, Seki M, Shinoda M, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Oki K, Nagoshi N, Watanabe K, Hibi T, Itano O, Hoshino K, Suzuki N, Kuroda T, Kitagawa Y. Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation. Ann Hepatol 18(2): 397-401, 2019
26.Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroentero 25(15): 1899-1906, 2019
27.Takeuchi M, Obara H, Kawakubo H, Shinoda M, Okabayashi K, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitago M, Yagi H, Abe Y, Oshima G, Hori S, Tsuruta M, Ishida T, Yokose T, Hirukawa K, Isobe Y, Sekimoto Y, Harada H, Maeda Y, Shito M, Kondo T, Sato Y, Kitagawa Y. Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trial. BMJ Open 9(5): web掲載6頁, 2019
28.Kurebayashi Y, Ojima H, Tsujikawa H, Kubota N, Maehara J, Abe Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology 68(3): 1025-1041, 2018
29.Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Hirukawa K, Mizota T, Hibi T, Itano O, Hoshino K, Kuroda T, Kitagawa Y. Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation. Transplant Proc 50(10): 3626-3634, 2018
30.Fujita Y, Kitago M, Abe T, Itano O, Shinoda M, Abe Y, Yagi H, Hibi T, Ishii M, Nakano Y, Okuma K, Hashimoto M, Takeuchi A, Masugi Y, Jinzaki M, Sakamoto M, Kitagawa Y. Evaluation of Pancreatic Fibrosis With Acoustic Radiation Force Impulse Imaging and Automated Quantification of Pancreatic Tissue Components. Pancreas 47(10): 1277-1282, 2018
31.Inomata K, Tajima K, Yagi H, Higashi H, Shimoda H, Matsubara K, Hibi T, Abe Y, Tsujikawa H, Kitago M, Shinoda M, Obara H, Itano O, A Soto-Gutierrez, Kitagawa Y. A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus. Sci Rep 8(14987): web掲載12頁, 2018
32.Amemiya R, Shinoda M, Yamada M, Ueno Y, Shimada K, Fujieda H, Yagi H, Mizota T, Nishiyama R, Oshima G, Yamada S, Matsubara K, Abe Y, Hibi T, Kitago M, Obara H, Itano O, Kitagawa Y. Hemoadsorption of high-mobility group box 1 using a porous polymethylmethacrylate fiber in a swine acute liver failure model. Int J Artif Organs 41(4): 190-200, 2018
33.Yamada Y, Hoshino K, Mori T, Kawaida M, Abe K, Ishihama H, Shimizu T, Takahashi N, Matsubara K, Hibi T, Abe Y, Yagi H, Shimojima N, Shinoda M, Kitago M, Obara H, Fuchimoto Y, Kameyama K, Kitagawa Y, Kuroda T. Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection. Hepatol Res 48(3): 360-366, 2018
34.Ito Y, Abe Y, Kitago M, Itano O, Kitagawa Y. Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy. World J Surg Oncol 16(1): web掲載8頁, 2018
35.Ito Y, Abe Y, Egawa T, Kitago M, Itano O, Kitagawa Y. Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy. Gastroenterol Res Pract 2018(6431254): web掲載7頁, 2018
36.Yamada Y, Hoshino K, Fuchimoto Y, Matsubara K, Hibi T, Yagi H, Abe Y, Shinoda M, Kitago M, Obara H, Yagi T, Okajima H, Kaido T, Uemoto S, Suzuki T, Kubota K, Yoshizumi T, Maehara Y, Inomata Y, Kitagawa Y, Egawa H, Kuroda T. Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation?The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation. Transplant Direct 4(2): web掲載6頁, 2018
37.Inomata K, Kitago M, Obara H, Fujii-Nishimura Y, Shinoda M, Yagi H, Abe Y, Hibi T, Matsubara K, Oshima G, Sekimoto Y, Inoue M, Itano O, Sakamoto M, Kitagawa Y. Concurrent presentation of an intraductal tubulopapillary neoplasm and intraductal papillary mucinous neoplasm in the branch duct of the pancreas, with a superior mesenteric artery aneurysm: a case report. World J Surg Oncol 16(1): 83-88, 2018
38.Endo Y, Kitago M, Miyajima A, Kurihara I, Kameyama K, Shinoda M, Yagi H, Abe Y, Hibi T, Takagi C, Nakano Y, Koizumi W, Itano O, Kitagawa Y. Two-stage resection of a bilateral pheochromocytoma and pancreaticneuroendocrine tumor in a patient with von Hippel-Lindau disease: Acase report. Int J Surg Case Rep. 44(2018): 139-142, 2018
39.Nakano Y, Kitago M, Matsuda S, Nakamura Y, Fujita Y, Imai S, Shinoda M, Yagi H, Abe Y, Hibi T, Nishimura Y, Takeuchi A, Endo Y, Itano O, Kitagawa Y. KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study. Br J Cancer 118(5): 662-669, 2018
40.Imai S, Shinoda M, Obara H, Kitago M, Hibi T, Abe Y, Yagi H, Matsubara K, Higashi H, Itano O, Kitagawa Y. Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients. Ann Transplant 9(23): 25-33, 2018
41.Iwashita Y, Hibi T, Ohyama T, Honda G, Yoshida M, Miura F, Takada T, Han HS, Hwang TL, Shinya S, Suzuki K, Umezawa A, Yoon YS, Choi IS, Huang WS, Chen KH, Watanabe M, Abe Y, Misawa T, Nagakawa Y, Yoon DS, Jang JY, Yu HC, Ahn KS, Kim SC, Song IS, Kim JH, Yun SS, Choi SH, Jan YY, Shan YS, Ker CG, Chan DC, Wu CC, Lee KT, Toyota N, Higuchi R, Nakamura Y, Mizuguchi Y, Takeda Y, Ito M, Norimizu S, Yamada S, Matsumura N, Shindoh J, Sunagawa H, Gocho T, Hasegawa H, Rikiyama T, Sata N, Kano N, Kitano S, Tokumura H, Yamashita Y, Watanabe G, Nakagawa K, Kimura T, Yamakawa T, Wakabayashi G, Mori R, Endo I, Miyazaki M, Yamamoto M. An opportunity in difficulty: Japan-Korea-Taiwan expert Delphi consensus on surgical difficulty during laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci 24(4): 191-198, 2017
42.Itoi T, Sugimoto M, Umeda J, Sofuni A, Tsuchiya T, Tsuji S, Tanaka R, Tonozuka R, Honjo M, Moriyasu F, Kasuya K, Nagakawa Y, Abe Y, Takano K, Kawachi S, Shimazu M, Soga T, Tomita M, Sunamura M. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Int J Mol Sci 18(4): web掲載13頁, 2017
43.Chiba N, Gunji T, Ozawa Y, Hikita K, Sano T, Tomita K, Abe Y, Kawachi S. Hepatopancreatoduodenectomy for perihilar cholangiocarcinoma following laparoscopic total gastrectomy. Int J Surg Case Rep 41: 209-211, 2017
44.Chiba N, Shimazu M, Takano K, Oshima G, Tomita K, Sano T, Okihara M, Ozawa Y, Hikita K, Gunji T, Abe Y, Koizumi K, Kawachi S. Predicting hepatic failure with a new diagnostic technique by preoperative liver scintigraphy and computed tomography: a pilot study in 123 patients undergoing liver resection. Patient Saf Surg 11(29): web掲載6頁, 2017
45.Nakano Y, Kitago M, Shinoda M, Abe Y, Yagi H, Hibi T, Takeuchi A, Aiura K, Itano O, Kitagawa Y. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study. Cancer Medicine 6(10): 2278-2286, 2017
46.Fujii T, Obara H, Matsubara K, Fujimura N, Yagi H, Hibi T, Abe Y, Kitago M, Shinoda M, Itano O, Tanabe M, Masugi Y, Sakamoto M, Kitagawa Y. Oral administration of cilostazol improves survival rate after rat liver ischemia/reperfusion injury. Journal of Surgical Research 213(1): 207-214, 2017
47.Ito Y, Abe Y, Handa K, Shibutani S, Egawa T, Nagashima A, Kitago M, Itano O, Kitagawa Y. Postoperative Delirium in Patients after Pancreaticoduodenectomy. Dig Surg 34(1): 78-85, 2017
48.Takagi C, Yagi H, Hieda M, Tajima K, Hibi T, Abe Y, Kitago M, Shinoda M, Itano O, Kitagawa Y. Mesenchymal Stem Cells Contribute to Hepatic Maturation of Human Induced Pluripotent Stem Cells. Eur Surg Res 58(1-2): 27-39, 2017
49.Higashi H, Obara H, Miyakoshi K, Shinoda M, Kitago M, Shimojima N, Abe Y, Hibi T, Yagi H, Matsubara K, Yamada Y, Itano O, Hoshino K, Kuroda T, Kitagawa Y. First successful perinatal management of pregnancy after ABO-incompatible liver transplantation. World J Gastroenterol 23(3): 547-550, 2017
50.Iwashita Y, Ohyama T, Honda G, Hibi T, Yoshida M, Miura F, Takada T, Han HS, Hwang TL, Shinya S, Suzuki K, Umezawa A, Yoon YS, Choi IS, Huang WS, Chen KH, Watanabe M, Abe Y, Misawa T, Nagakawa Y, Yoon DS, Jang JY, Yu HC, Ahn KS, Kim SC, Song IS, Kim JH, Yun SS, Choi SH, Jan YY, Sheen-Chen SM, Shan YS, Ker CG, Chan DC, Lee KT, Toyota N, Higuchi R, Nakamura Y, Mizuguchi Y, Takeda Y, Ito M, Norimizu S, Yamada S, Matsumura N, Shindoh J, Sunagawa H, Hasegawa H, Rikiyama T, Sata N, Kano N, Kitano S, Tokumura H, Yamashita Y, Watanabe G, Nakagawa K, Kimura T, Yamakawa T, Wakabayashi G, Endo I, Miyazaki M, Yamamoto M. What are the appropriate indicators of surgical difficulty during laparoscopic cholecystectomy? Results from a Japan-Korea-Taiwan multinational survey. J Hepatobiliary Pancreat Sci 23(9): 533-547, 2016
51.Kishida N, Shinoda M, Itano O, Obara H, Kitago M, Hibi T, Yagi H, Abe Y, Matsubara K, Odaira M, Tanabe M, Shimazu M, Kitagawa Y. Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation. Ann Transplant 21: 755-764, 2016
52.Fujita Y, Kitago M, Masugi Y, Itano O, Shinoda M, Abe Y, Hibi T, Yagi H, Fujii-Nishimura Y, Sakamoto M, Kitagawa Y. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol 22(41): 9222-9228, 2016
53.Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res 46(11): 1118-1128, 2016
54.Katsuki Y, Yagi H, Okitsu T, Kitago M, Tajima K, Kadota Y, Hibi T, Abe Y, Shinoda M, Itano O, Takeuchi S, Kitagawa Y. Endocrine pancreas engineered using porcine islets and partial pancreatic scaffolds. Pancreatology 16(5): 922-930, 2016
55.Kishida N, Matsuda S, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Hibi T, Masugi Y, Aiura K, Sakamoto M, Kitagawa Y. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. BMC Gastroenterol 16(1): web掲載13頁, 2016
56.Yamada T, Okabayashi K, Hasegawa H, Tsuruta M, Abe Y, Ishida T, Matsui S, Kitagawa Y. Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery. Ann Surg Oncol 23(Suppl 2): S236-S241, 2016
57.Ishikawa J, Oshima M, Iwasaki F, Suzuki R, Park J, Nakao K, Matsuzawa-Adachi Y, Mizutsuki T, Kobayashi A, Abe Y, Kobayashi E, Tezuka K, Tsuji T. Hypothermic temperature effects on organ survival and restoration. Sci Rep. 2015 Apr;5:9563.
58.Tanaka M, Kitago M, Akiyama N, Iwamaru A, Yamamoto T, Suzuki F, Hibi T, Abe Y, Yagi H, Shinoda M, Itano O, Ogata K, Kitagawa Y. Usefulness of immunohistochemical studies in diagnosing metachronous gallbladder and small intestinal metastases from lung cancer with gastrointestinal hemorrhage: a case report. World J Surg Oncol. 2015 Feb;13(1):63.
59.Shinoda M, Kishida N, Itano O, Ei S, Ueno A, Kitago M, Abe Y, Hibi T, Yagi H, Masugi Y, Tanabe M, Aiura K, Sakamaoto M, Tanimoto A, Kitagawa Y. Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature. World J Surg Oncol. 2015 Apr;13(1):144.
60.Yamada T, Okabayashi K, Hasegawa H, Tsuruta M, Abe Y, Ishida T, Matsui S, Kitagawa Y. Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery. Ann Surg Oncol. 2015 Mar; Epub ahead of print.
61.Itano O, Oshima G, Minagawa T, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Ikoma N, Aiko S, Kawaida M, Masugi Y, Kameyama K, Sakamoto M, Kitagawa Y. Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc. 2015 Mar; Epub ahead of print.
62.Hibi T, Shinoda M, Itano O, Obara H, Kitago M, Abe Y, Yagi H, Tanaka M, Hoshino K, Fujino A, Kuroda T, Kawachi S, Tanabe M, Shimazu M, Kitagawa Y. Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis. Hepatol Res. 2015 Jan; Epub ahead of print.
63.Kishida N, Hibi T, Itano O, Okabayashi K, Shinoda M, Kitago M, Abe Y, Yagi H, Kitagawa Y. Validation of Hepatectomy for Elderly Patients with Hepatocellular Carcinoma. Ann Surg Oncol. 2015 Jan; Epub ahead of print.
64.Tanaka M, Shinoda M, Takayanagi A, Oshima G, Nishiyama R, Fukuda K, Yagi H, Hayashida T, Masugi Y, Suda K, Yamada S, Miyasho T, Hibi T, Abe Y, Kitago M, Obara H, Itano O, Takeuchi H, Sakamoto M, Tanabe M, Maruyama I, Kitagawa Y. Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model. J Surg Res. 2015 Apr;194(2):571-80.
65.Ei S, Hibi T, Tanabe M, Itano O, Shinoda M, Kitago M, Abe Y, Yagi H, Okabayashi K, Sugiyama D, Wakabayashi G, Kitagawa Y. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. Ann Surg Oncol. 2015 Apr;22(4):1294-300.
66.Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, Hasegawa Y, Katagiri T, Takagi C, Itano O, Kaneko H, Wakabayashi G. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53.
67.Kishida N, Shinoda M, Masugi Y, Itano O, Fujii-Nishimura Y, Ueno A, Kitago M, Hibi T, Abe Y, Yagi H, Tanimoto A, Tanabe M, Sakamaoto M, Kitagawa Y. Cystic tumor of the liver without ovarian-like stroma or bile duct communication: two case reports and a review of the literature. World J Surg Oncol. 2014 Jul 21;12:229.
68.Abe Y, Itano O, Kitago M, Shinoda M, Yagi H, Hibi T, Takano K, Chiba N, Kawachi S, Shimazu M, Kitagawa Y. Computer assisted surgery, preoperative planning and navigation for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2014 Apr;21(4):251-5.
69.Kadota Y, Yagi H, Inomata K, Matsubara K, Hibi T, Abe Y, Kitago M, Shinoda M, Obara H, Itano O, Kitagawa Y. Mesenchymal stem cells support hepatocyte function in engineered liver grafts. Organogenesis. 2014 Apr 1;10(2):268-77.
70.Shinoda M, Kadota Y, Tsujikawa H, Masugi Y, Itano O, Ueno A, Mihara K, Hibi T, Abe Y, Yagi H, Kitago M, Kawachi S, Tanimoto A, Sakamoto M, Tanabe M, Kitagawa Y. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Surg Oncol. 2013 May 4;11:97.
71.Kadota Y, Shinoda M, Tanabe M, Tsujikawa H, Ueno A, Masugi Y, Oshima G, Nishiyama R, Tanaka M, Mihara K, Abe Y, Yagi H, Kitago M, Itano O, Kawachi S, Aiura K, Tanimoto A, Sakamaoto M, Kitagawa Y. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review. World J Surg Oncol. 2013 Mar 21;11:75.
72.Abe Y, Kasuya K, Itoi T, Kikuchi S, Ikeuchi N, Ishii K, Serizawa H, Shimazu M. Hepatobiliary cystadenoma of the liver prolapsing into the extrahepatic bile duct (with video). Gastrointest Endosc. 2012 May;75(5):1099; discussion 1099-1100.
73.Kasuya K, Tsuchida A, Nagakawa Y, Suzuki Y, Suzuki M, Aoki T, Abe Y, Shimazu M, Itoi T, Sofuni A. Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. Hepatogastroenterology. 2012 Jul-Aug;59(117):1609-13.
74.Kasuya K, Tsuchida A, Nagakawa Y, Suzuki M, Abe Y, Itoi T, Serizawa H, Nagao T, Shimazu M, Aoki T. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Oncol Rep. 2011 Dec;26(6):1399-406.
75.Itoi T, Kasuya K, Abe Y, Isayama H. Endoscopic placement of a new short-term biodegradable pancreatic and biliary stent in an animal model: a preliminary feasibility study (with videos). J Hepatobiliary Pancreat Sci. 2011 May;18(3):463-7.
76.Kasuya K, Shimazu M, Abe Y, Kikuchi S, Itoi T, Ikada Y, Aoki T, Tsuchida A. A newly developed degradable stent for pancreaticojejunostomy after pancreatoduodenectomy. Int Surg. 2010 Jul-Sep;95(3):247-56. PubMed PMID: 21067005.
77.Abe Y, Urakami H, Ostanin D, Zibari G, Hayashida T, Kitagawa Y, Grisham MB. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts. PLoS One. 2009 Nov 23;4(11):e7840.
78.Abe Y, Hines IN, Zibari G, Pavlick K, Gray L, Kitagawa Y, Grisham MB. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med. 2009 Jan 1;46(1):1-7.
79.Abe Y, Hines I, Zibari G, Grisham MB. Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury. Arch Biochem Biophys. 2009 Apr 15;484(2):232-7.
80.Urakami H, Abe Y, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury. Clin Exp Pharmacol Physiol. 2007 Sep;34(9):912-9.
81.Morise Z, Yamafuji K, Tsuji T, Asami A, Takeshima K, Hayashi N, Baba H, Yoshida F, Abe Y, Tokura Y. A giant retention cyst of the pancreas (cystic dilatation of dorsal pancreatic duct) associated with pancreas divisum. J Gastroenterol. 2002;37(12):1079-82.